Get Pacific Biosciences of California alerts:A number of equities research analysts have recently commented on the stock. Pacific Biosciences of California had a negative net margin of 336.40% and a negative return on equity of 66.75%. As a group, research analysts expect that Pacific Biosciences of California will post -0.72 earnings per share for the current fiscal year. Pacific Biosciences of California Company Profile(Get Free Report)Pacific Biosciences of California, Inc designs, develops, and manufactures sequencing solution to resolve genetically complex problems. Featured ArticlesReceive News & Ratings for Pacific Biosciences of California Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pacific Biosciences of California and related companies with MarketBeat.com's FREE daily email newsletter.